Rapid Pathogen Detection Diagnostics Market, By Product Type (Rapid Test Kits, Reagents & Consumables, and Analyzers & Instruments), By Technology, By Detection Method, By Pathogen Type, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4707
|
Published Date
February 2026
|
Pages
290
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Rapid Pathogen Detection Diagnostics Market size was valued at US$ 20,980.10 Million in 2024, expanding at a CAGR of 4.98% from 2025 to 2032.
Rapid pathogen detection diagnostics are testing solutions designed to quickly identify bacterial, viral, and fungal pathogens in clinical, food, and environmental samples. The growing need for timely disease management, outbreak control, and food safety monitoring is driving demand for these diagnostics across healthcare, pharmaceutical, and food testing sectors. Significant opportunities exist in developing highly sensitive, multiplexed assays that deliver rapid and accurate results, which are crucial for point-of-care testing, hospital infection control, and public health surveillance. A key trend is the integration of molecular techniques, microfluidics, and portable platforms to enhance speed, portability, and usability.
In the face of a substantial global infectious disease burden, rapid diagnostics are increasingly vital: according to the World Health Organization (WHO), infectious diseases are responsible for an estimated 15million deaths annually worldwide, highlighting the ongoing need for effective detection tools to manage outbreaks and improve health outcomes. However, challenges such as high development costs, complex sample preparation, and stringent regulatory requirements limit widespread adoption in lowresource settings or largescale field applications. These challenges, in turn, create opportunities for innovation in simplified, costeffective, and highthroughput diagnostic solutions that can improve accessibility and support global health initiatives.
Rapid Pathogen Detection Diagnostics Market- Market Dynamics
Increasing Demand for Rapid and Accurate Pathogen Detection in Healthcare and Food Safety
The increasing focus on rapid pathogen detection in healthcare, pharmaceutical, and food testing sectors is driving strong demand for rapid pathogen detection diagnostics, which are essential for outbreak prevention, patient safety, and food quality assurance. Hospitals, diagnostic laboratories, and food manufacturers are prioritizing tests that deliver fast, accurate, and reproducible results to minimize the risk of contamination and disease spread. The shift toward point-of-care testing and portable diagnostic platforms is further boosting adoption, enabling on-site analysis with minimal equipment and immediate actionable insights. Rising incidences of infectious diseases, foodborne outbreaks, and global surveillance initiatives are also expanding the use of rapid diagnostics. For instance, during recent influenza and norovirus outbreaks, rapid testing facilitated quicker pathogen identification and containment. According to the World Health Organization (WHO), in 2024, over 85% of member states reported implementing national pathogen surveillance programs that included rapid diagnostic testing for high-priority pathogens, highlighting significant government investment in outbreak preparedness and public health monitoring. The growing deployment of multiplexed, automated, and user-friendly systems in clinical and food-testing environments continues to accelerate market growth.
Rapid Pathogen Detection Diagnostics Market- Segmentation Analysis:
The Global Rapid Pathogen Detection Diagnostics Market is segmented on the basis of Product Type, Technology, Detection Method, Pathogen Type, End User, and Region.
In the rapid pathogen detection diagnostics market, the product type segmentation includes rapid test kits, reagents & consumables, and analyzers & instruments. Rapid test kits hold the highest priority due to their portability, ease of use, and ability to deliver immediate results at point-of-care settings, making them indispensable for outbreak control, hospital diagnostics, and food safety monitoring. Governments worldwide emphasize the deployment of rapid diagnostic tools to prevent the spread of infectious diseases; for instance, public health authorities in the U.S., EU, and Asia-Pacific have integrated rapid test kits into national pandemic preparedness programs, with over 60% of frontline hospitals and public health laboratories equipped with validated rapid detection kits. Reagents & consumables rank second, supporting molecular, immunoassay, and culture-based testing workflows in both laboratory and automated platforms. These materials are critical for maintaining test accuracy, reproducibility, and sensitivity, which is particularly emphasized in government-regulated food and environmental safety programs. Analyzers & instruments follow, providing the infrastructure for high-throughput, automated, and multiplexed testing. While they require higher capital investment and technical expertise, these systems are essential for large-scale diagnostic laboratories and public health monitoring initiatives, where regulatory agencies mandate standardized and validated equipment for pathogen surveillance.
From a technology perspective, the market is divided into molecular diagnostics, immunoassays, biosensor-based detection, and microfluidics. Molecular diagnostics hold the highest priority due to their high sensitivity, specificity, and widespread adoption for detecting bacterial, viral, and fungal pathogens across clinical, food, and environmental testing applications. Governments globally, including the U.S. CDC, European ECDC, and national health authorities in Asia, have recognized molecular diagnostics as the gold standard for pathogen detection, recommending their use in outbreak monitoring and mandatory surveillance programs. Immunoassays rank second, widely employed for antigen–antibody detection in laboratories and point-of-care environments due to their robustness, scalability, and integration into automated workflows. Biosensor-based detection follows, gaining traction for real-time, label-free monitoring in compact, portable formats, particularly in field testing and food safety inspections, supported by government initiatives to enhance early warning systems for pathogens. Microfluidics ranks next, enabling miniaturized, high-throughput, and multiplexed testing, though its adoption is currently limited by development complexity and infrastructure requirements. Overall, technology prioritization reflects global regulatory emphasis on rapid, sensitive, and reliable pathogen detection tools that can be deployed across diverse environments to protect public health and ensure food and environmental safety.
Rapid Pathogen Detection Diagnostics Market- Geographical Insights
North America leads the rapid pathogen detection diagnostics market, accounting for approximately 40.9% of global revenue in 2025. This dominance is supported by advanced healthcare infrastructure, widespread adoption of next-generation diagnostic technologies, and strong public health surveillance programs, particularly in the United States. Europe holds the second-largest share, driven by robust clinical diagnostics adoption, supportive regulatory frameworks, and initiatives to integrate rapid testing throughout healthcare systems. The Asia-Pacific region is the fastest-growing market, fueled by rising infectious disease prevalence, expanding healthcare access in countries such as China, India, and Japan, and increased investment in point-of-care and molecular diagnostic platforms. Latin America and the Middle East & Africa are gradually expanding, supported by improving diagnostic infrastructure and government health initiatives. Key strategic developments include Revvity’s acquisition of a CRISPR-based pathogen detection startup in September 2024 to enhance rapid testing capabilities, as well as cross-border partnerships that improve technology access and regional distribution networks.
Rapid Pathogen Detection Diagnostics Market- Country Insights
At the country level, the United States is the leading contributor to the rapid pathogen detection diagnostics market, driven by advanced healthcare infrastructure, widespread adoption of molecular and point-of-care technologies, and robust public health surveillance programs that emphasize early pathogen detection and outbreak control. In Europe, countries such as Germany, the United Kingdom, and France hold significant market shares, supported by stringent regulations, well-established clinical laboratory networks, and national initiatives to integrate rapid diagnostics into healthcare systems, thereby strengthening disease surveillance and response. The Asia-Pacific region, led by China, Japan, and India, is the fastest-growing market due to rising healthcare investments, increasing prevalence of infectious diseases, and expanding access to rapid testing platforms, particularly in China’s tier2 and tier3 cities and across India. Strategic industry developments further reinforce country-level growth; for instance, Revvity’s 2024 acquisition of a rapid diagnostics technology provider expanded its pathogen detection portfolio across the U.S. and Europe, while a 2025 partnership between Roche Diagnostics and regional distributors in Japan improved local access to rapid pathogen detection solutions.
Rapid Pathogen Detection Diagnostics Market- Competitive Landscape:
The rapid pathogen detection diagnostics market is moderately competitive, comprising both global and regional players focused on technological innovation, strategic partnerships, and expanded product offerings. Leading companies include Thermo Fisher Scientific, Roche Diagnostics, bioMérieux, QIAGEN, Danaher Corporation (Cepheid), Abbott Laboratories, BD (Becton, Dickinson and Company), Eurofins Scientific, Siemens Healthineers, and Agilent Technologies. These companies leverage extensive R&D investment, broad distribution networks, and advanced molecular and immunoassay technologies to maintain market leadership. Strategic acquisitions and collaborations are shaping competition; for example, Revvity’s acquisition of a CRISPR-based pathogen detection startup in September 2024 strengthened its rapid diagnostics portfolio, while Roche Diagnostics and bioMérieux partnered in 2025 to co-develop integrated rapid platforms for respiratory and bloodstream pathogen detection. Continuous product launches, platform enhancements, and cross-sector partnerships further intensify competitive differentiation, as companies aim to deliver faster, more accurate, and multiplexed pathogen detection solutions.
Recent Developments:
- In December 2025, Hardy Diagnostics entered a strategic partnership with NEMIS Technologies to introduce NEMIS’s NLight™ rapid on-site pathogen detection technology to the North American market, enabling faster and reliable pathogen testing for food safety and environmental monitoring.
- In February 2024, QIAGEN launched two new QIAstat Dx syndromic testing panels in India—the Gastrointestinal Panel 2 and the Meningitis/Encephalitis Panel—receiving CDSCO regulatory approval to facilitate faster, accurate multiplex infectious disease diagnosis using real-time PCR on single-use cartridges.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Agilent Technologies
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Cepheid
- Danaher Corporation
- DiaSorin
- Fujifilm Holdings
- GenMark Diagnostics
- Hologic
- Illumina
- Luminex Corporation
- Meridian Bioscience
- Qiagen
- QuidelOrtho
- Roche Diagnostics
- Sekisui Diagnostics
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific
- Others
GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Rapid Test Kits
- Reagents & Consumables
- Analyzers & Instruments
GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Immunoassays
- Molecular Diagnostics
- Biosensor-Based Detection
- Microfluidics
GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET, BY DETECTION METHOD- MARKET ANALYSIS, 2019 - 2032
- Optical Detection
- Fluorescence Detection
- Electrochemical Detection
- Lateral Flow Assays
GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET, BY PATHOGEN TYPE- MARKET ANALYSIS, 2019 - 2032
- Bacterial Pathogens
- Viral Pathogens
- Fungal Pathogens
GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals & Clinics
- Diagnostic Laboratories
- Point-of-Care Settings
- Food & Environmental Testing Labs
GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Rapid Pathogen Detection Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Rapid Pathogen Detection Diagnostics Market Snippet by Product Type
2.1.2. Rapid Pathogen Detection Diagnostics Market Snippet by Technology
2.1.3. Rapid Pathogen Detection Diagnostics Market Snippet by Detection Method
2.1.4. Rapid Pathogen Detection Diagnostics Market Snippet by Pathogen Type
2.1.5. Rapid Pathogen Detection Diagnostics Market Snippet by End User
2.1.6. Rapid Pathogen Detection Diagnostics Market Snippet by Country
2.1.7. Rapid Pathogen Detection Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. Rapid Pathogen Detection Diagnostics Key Market Trends
3.1. Rapid Pathogen Detection Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Rapid Pathogen Detection Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Rapid Pathogen Detection Diagnostics Market Opportunities
3.4. Rapid Pathogen Detection Diagnostics Market Future Trends
4. Rapid Pathogen Detection Diagnostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Rapid Pathogen Detection Diagnostics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Rapid Pathogen Detection Diagnostics Market Landscape
6.1. Rapid Pathogen Detection Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Rapid Pathogen Detection Diagnostics Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Rapid Test Kits
7.1.3. Reagents & Consumables
7.1.4. Analyzers & Instruments
8. Rapid Pathogen Detection Diagnostics Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
8.1.2. Immunoassays
8.1.3. Molecular Diagnostics
8.1.4. Biosensor-Based Detection
8.1.5. Microfluidics
9. Rapid Pathogen Detection Diagnostics Market – By Detection Method
9.1. Overview
9.1.1. Segment Share Analysis, By Detection Method, 2024 & 2032 (%)
9.1.2. Optical Detection
9.1.3. Fluorescence Detection
9.1.4. Electrochemical Detection
9.1.5. Lateral Flow Assays
10. Rapid Pathogen Detection Diagnostics Market – By Pathogen Type
10.1. Overview
10.1.1. Segment Share Analysis, By Pathogen Type, 2024 & 2032 (%)
10.1.2. Bacterial Pathogens
10.1.3. Viral Pathogens
10.1.4. Fungal Pathogens
11. Rapid Pathogen Detection Diagnostics Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
11.1.2. Hospitals & Clinics
11.1.3. Diagnostic Laboratories
11.1.4. Point-of-Care Settings
11.1.5. Food & Environmental Testing Labs
12. Rapid Pathogen Detection Diagnostics Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Rapid Pathogen Detection Diagnostics Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Rapid Pathogen Detection Diagnostics Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Rapid Pathogen Detection Diagnostics Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Rapid Pathogen Detection Diagnostics Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Rapid Pathogen Detection Diagnostics Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Rapid Pathogen Detection Diagnostics Industry
13.1. Competitive Dashboard
13.1.1. Competitive Benchmarking
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Abbott Laboratories
13.2.2. Agilent Technologies
13.2.3. Becton, Dickinson and Company
13.2.4. Bio-Rad Laboratories
13.2.5. Cepheid
13.2.6. Danaher Corporation
13.2.7. DiaSorin
13.2.8. Fujifilm Holdings
13.2.9. GenMark Diagnostics
13.2.10. Hologic
13.2.11. Illumina
13.2.12. Luminex Corporation
13.2.13. Meridian Bioscience
13.2.14. Qiagen
13.2.15. QuidelOrtho
13.2.16. Roche Diagnostics
13.2.17. Sekisui Diagnostics
13.2.18. Siemens Healthineers
13.2.19. Sysmex Corporation
13.2.20. Thermo Fisher Scientific
13.2.21. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Agilent Technologies
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Cepheid
- Danaher Corporation
- DiaSorin
- Fujifilm Holdings
- GenMark Diagnostics
- Hologic
- Illumina
- Luminex Corporation
- Meridian Bioscience
- Qiagen
- QuidelOrtho
- Roche Diagnostics
- Sekisui Diagnostics
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific
- Others
GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Rapid Test Kits
- Reagents & Consumables
- Analyzers & Instruments
GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Immunoassays
- Molecular Diagnostics
- Biosensor-Based Detection
- Microfluidics
GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET, BY DETECTION METHOD- MARKET ANALYSIS, 2019 - 2032
- Optical Detection
- Fluorescence Detection
- Electrochemical Detection
- Lateral Flow Assays
GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET, BY PATHOGEN TYPE- MARKET ANALYSIS, 2019 - 2032
- Bacterial Pathogens
- Viral Pathogens
- Fungal Pathogens
GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals & Clinics
- Diagnostic Laboratories
- Point-of-Care Settings
- Food & Environmental Testing Labs
GLOBAL RAPID PATHOGEN DETECTION DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
